EuroBio 2007

EuroBio 2007EuroBio 2007 will take place in Lille (North of France's capital city) from the 26th to the 28th of September 2007. Last year, EuroBiO 2006 Paris was attended by almost 5,000 people, making it the number 1 springboard for meeting the key players in bioscience and bio-industry in Europe.

The four main aspects that make this event unique – the conferences, the trade show, the business convention and the recruitment drive – bring together partners from the worlds of Industry, Research and Finance. All aspects of the subject will be represented, from the "health sector" applications for biotechnology (Healthcare , pharmaceuticals, diagnosis) to the fields in which biotechnology provides technological solutions and product applications (cosmetics, chemistry, the environment, the food industry...).

EuroBiO aims at gathering the whole European biotech and pharmaceutical communities around an operating platform based on the following 4 pillars:

  • EuroBiO Trade Show, the exhibition that will gather 400 international exhibitors on 8000 m².
  • EuroBiO Partnering, the business convention, a genuine catalyst for business development and technology transfer projects among 400 companies and organizations.
  • EuroBiO Career Fair, the recruitment drive, a tremendous opportunity bringing together companies, universities and highly-qualified job seekers.
  • EuroBiO Conferences, the economic and scientific workshops, round tables and lectures, featuring 200 key note speakers.

The conferences are organized according to four major tracks, and about 10 sessions each:

  • Biotech Economy and Business Development
  • Red Biotechnology
  • White and Green Biotech
  • Regulatory Affairs / IP / Technology

EuroBiO 2007 returns to Lille with ever-greater ambitions, in line with how the event has succeeded in attracting more international interest at each edition, be it at the trade exhibition (70% of which is already attributed) or in the congress-member delegations.

EuroBiOpartnering is the business convention, playing the role of a genuine catalyst for technology transfer projects. It also encourages and supports inter-company and business-academic laboratory research collaboration. This year, EuroBiOpartnering should result in 1,000 business meetings.

Above all, EuroBiO is also a question of knowledge, enhanced by first-hand reports and exchanges of experiences. There are some 40 lectures bringing together more than 200 speakers of world renown.

As there are no state boundaries in the biotechnology sector, EuroBio is committed to encouraging action, meetings and the growth of the bioscience/bioindustry/pharma sector on an international scale.

For further information, please visit:
http://www.eurobio-event.com

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Computer Models Open Door to Far Mor…

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only...

New Biomarkers to Detect Colorectal Canc…

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer. In a...

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...

AI Model Identifies Potential Risk Genes…

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can...

AI Tool that may Assist Underserved Hosp…

As the fields of healthcare and technology increasingly evolve and intersect, researchers are collaborating on the best ways to use emerging technologies such as artificial intelligence (AI) to care for...